ARCHIVES

Varmus, In Letter To Institute Pasteur, Reopens Discussion Of Test Kit Royalties

This article is from The Cancer Letter archive.

Vol. 20 No. 26 | July 1, 1994

Download PDF Visit The Full Archive

Related Articles

Control AC Hear Report On High Risk conference, Messer Survey

September 6, 1974

ACC Survey Preliminary Finding: Three Cancer DRG Categories “Clearly Underpaid Across The Board”

January 25, 1985

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012

Nine More Reported In Range Of CCOP 3 Recompetition

February 2, 1990

Groups Urge FDA To Take Action Against Tobacco Products

June 27, 2014

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

April 29, 1988